Reprogramming the fate of human glioma cells to impede brain tumor development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reprogramming the fate of human glioma cells to impede brain tumor development

Published:2014-10 Issue:10 Volume:5 Page:e1463-e1463
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Su Z,Zang T,Liu M-L,Wang L-L,Niu W,Zhang C-L

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis2014425.pdf

Reference43 articles.

1. Sukhdeo K, Hambardzumyan D, Rich JN . Glioma development: where did it all go wrong? Cell 2011; 146: 187–188.

2. Chen J, McKay RM, Parada LF . Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell 2012; 149: 36–47.

3. Bleeker FE, Molenaar RJ, Leenstra S . Recent advances in the molecular understanding of glioblastoma. J Neurooncol 2012; 108: 11–27.

4. Mei J, Bachoo R, Zhang CL . MicroRNA-146a inhibits glioma development by targeting Notch1. Mol Cell Biol 2011; 31: 3584–3592.

5. Guessous F, Zhang Y, Kofman A, Catania A, Li Y, Schiff D et al. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle 2010; 9: 1031–1036.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reprogramming of astrocytes and glioma cells into neurons for central nervous system repair and glioblastoma therapy;Biomedicine & Pharmacotherapy;2024-07

2. Biomimetic three-dimensional glioma model printed in vitro for the studies of glioma cells and neurons interactions;International Journal of Bioprinting;2023-08-16

3. NeuroD4 converts glioblastoma cells into neuron-like cells through the SLC7A11-GSH-GPX4 antioxidant axis;Cell Death Discovery;2023-08-15

4. Long-acting therapeutic delivery systems for the treatment of gliomas;Advanced Drug Delivery Reviews;2023-06

5. Regulation of Cell Plasticity by Bromodomain and Extraterminal Domain (BET) Proteins: A New Perspective in Glioblastoma Therapy;International Journal of Molecular Sciences;2023-03-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3